We recently published a list of 10 Stocks Insiders Spent The Most Money On Recently. In this article, we are going to take a ...
In this article, we are going to take a look at where Metsera (NASDAQ:MTSR) stands against other stocks insiders spent the most money on recently. As the broader market continues to rise this year ...
Sixth among 10 stocks insiders spent the most money on recently is Metsera, a clinical-stage biotechnology company. Metsera is engaged in the development of injectable and oral nutrient-stimulated ...
Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs. Just nine months after emerging from stealth with a $290 million Series A ...
Metsera and Maze Therapeutics have become the second and third biotechs to complete an initial public offering (IPO) on the Nasdaq this year, raising $275 million and $140 million, respectively.
After hours: 7:53:40 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results